Sam-A Pharm. Co., Ltd (KOSDAQ:009300)

South Korea flag South Korea · Delayed Price · Currency is KRW
15,340
-390 (-2.48%)
At close: Mar 9, 2026
-5.89%
Market Cap 93.63B
Revenue (ttm) 76.66B
Net Income (ttm) 13.19B
Shares Out 6.10M
EPS (ttm) 2,160.45
PE Ratio 7.10
Forward PE n/a
Dividend 800.00 (5.09%)
Ex-Dividend Date Dec 29, 2025
Volume 5,918
Average Volume 13,791
Open 15,720
Previous Close 15,730
Day's Range 15,050 - 15,720
52-Week Range 14,730 - 19,250
Beta 0.22
RSI 39.31
Earnings Date Nov 14, 2025

About Sam-A Pharm.

Sam-A Pharm. Co., Ltd operates as a pharmaceutical company in South Korea. The company offers a range of pharmaceutical products in the areas of respiratory, antibiotics, anti-virals, anti-histamines, anti-fungals, dermatology, pain/inflammation, gastrointestinal, cardiovascular, metabolism, urological, and steroids, as well as psychotropic agents; and OTC products in the areas of respiratory, ant-analgesics, gastro-intestinal, topical, oral, and anti-histamines. It provides NOMA MEGAFFECT for stress relief, eye care, memory and blood lipid con... [Read more]

Industry Pharmaceutical Preparations
Founded 1945
Employees 300
Stock Exchange KOSDAQ
Ticker Symbol 009300
Full Company Profile

Financial Performance

In 2024, Sam-A Pharm.'s revenue was 95.58 billion, a decrease of -1.68% compared to the previous year's 97.21 billion. Earnings were 22.08 billion, an increase of 3.30%.

Financial Statements

News

There is no news available yet.